Skip to content

STRIVE, INC.: 10-Q filed 2025-08-05

What STRIVE, INC. reported in its quarterly report filed 2025-08-05 (fiscal Q2 2025): 34 published measures, 95 facts as tagged in accession 0001213900-25-071724.

This filing

Form
10-Q (quarterly report)
Filed
2025-08-05
Fiscal period
fiscal Q2 2025
Accession
0001213900-25-071724 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All STRIVE, INC. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2025-06-303,262,441USD
At 2024-12-313,217,466USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2025-06-30578,447USD
At 2024-12-31430,895USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2025-06-302,683,994USD
At 2025-03-314,533,745USD
At 2024-12-312,786,571USD
At 2024-06-302,097,090USD
At 2024-03-311,862,255USD
At 2023-12-312,922,288USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2025-06-302,518,441USD
At 2024-12-312,660,624USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2025-04-01 to 2025-06-30-2,664,611USD91
2025-01-01 to 2025-06-30-4,288,829USD181
2025-01-01 to 2025-03-31-1,624,218USD90
2024-04-01 to 2024-06-30-1,726,537USD91
2024-01-01 to 2024-06-30-3,113,441USD182
2024-01-01 to 2024-03-31-1,386,904USD91

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2025-01-01 to 2025-06-30-3,261,053USD181
2024-01-01 to 2024-06-30-2,322,108USD182

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

PeriodValueUnitDays
2024-01-01 to 2024-06-3014,761USD182

Revenue

Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.

PeriodValueUnitDays
2025-04-01 to 2025-06-30173,259USD91
2025-01-01 to 2025-06-30344,008USD181
2024-04-01 to 2024-06-3092,966USD91
2024-01-01 to 2024-06-30217,807USD182

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2025-01-01 to 2025-06-303,118,870USD181
2024-01-01 to 2024-06-301,539,434USD182

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

PeriodValueUnitDays
2024-01-01 to 2024-06-30-214,761USD182

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2025-06-30-16,330,381USD
At 2024-12-31-12,006,357USD

Basic weighted-average shares

Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.

PeriodValueUnitDays
2025-04-01 to 2025-06-3015,591,759shares91
2025-01-01 to 2025-06-3014,380,325shares181
2024-04-01 to 2024-06-302,960,126shares91
2024-01-01 to 2024-06-302,897,504shares182

Diluted weighted-average shares

Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.

PeriodValueUnitDays
2025-04-01 to 2025-06-3015,591,759shares91
2025-01-01 to 2025-06-3014,380,325shares181
2024-04-01 to 2024-06-302,960,126shares91
2024-01-01 to 2024-06-302,897,504shares182

Basic earnings per share

Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.

PeriodValueUnitDays
2025-04-01 to 2025-06-30-0.17USD/shares91
2025-01-01 to 2025-06-30-0.3USD/shares181
2024-04-01 to 2024-06-30-0.58USD/shares91
2024-01-01 to 2024-06-30-1.07USD/shares182

Diluted earnings per share

Reported earnings or loss per share under dilution rules. Antidilutive instruments may be excluded. A diluted value can equal the basic value without implying no potential dilution.

PeriodValueUnitDays
2025-04-01 to 2025-06-30-0.17USD/shares91
2025-01-01 to 2025-06-30-0.3USD/shares181
2024-04-01 to 2024-06-30-0.58USD/shares91
2024-01-01 to 2024-06-30-1.07USD/shares182

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2025-06-308,758USD
At 2024-12-3110,114USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

PeriodValueUnitDays
2025-01-01 to 2025-06-301,067,382USD181
2024-01-01 to 2024-06-30739,309USD182

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2025-04-01 to 2025-06-30-2,692,310USD91
2025-01-01 to 2025-06-30-4,349,406USD181
2024-04-01 to 2024-06-30-1,726,537USD91
2024-01-01 to 2024-06-30-3,113,441USD182

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2025-06-302,744,183USD
At 2024-12-312,697,852USD

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2025-06-30578,447USD
At 2024-12-31430,895USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2025-04-01 to 2025-06-302,865,569USD91
2025-01-01 to 2025-06-304,693,414USD181
2024-04-01 to 2024-06-301,819,503USD91
2024-01-01 to 2024-06-303,331,248USD182

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

PeriodValueUnitDays
2025-01-01 to 2025-06-30182,484USD181
2024-01-01 to 2024-06-30238,739USD182

Cash including restricted cash

Cash, cash equivalents and restricted cash as reported in the cash flow reconciliation. Restricted amounts are not freely available, so this is not the same as unrestricted cash.

PeriodValueUnitDays
At 2025-06-302,518,441USD
At 2024-12-312,660,624USD
At 2024-06-301,926,888USD
At 2023-12-312,924,323USD

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

PeriodValueUnitDays
At 2025-06-3019,012,713USD
At 2024-12-3114,791,922USD

Gross property, plant and equipment

Cost of property, plant and equipment before accumulated depreciation. Historical cost does not indicate current value or replacement cost.

PeriodValueUnitDays
At 2025-06-3013,559USD
At 2024-12-3113,559USD

Accumulated depreciation on property, plant and equipment

Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.

PeriodValueUnitDays
At 2025-06-304,801USD
At 2024-12-313,445USD

Net intangible assets excluding goodwill

Intangible assets other than goodwill after amortization and impairment. Internally developed intangibles are usually not recognized, so this understates what a company relies on.

PeriodValueUnitDays
At 2025-06-30509,500USD
At 2024-12-31509,500USD

Current contract liabilities

Consideration received before performance obligations are satisfied, often called deferred revenue. It is an obligation to deliver, not earned revenue or cash available.

PeriodValueUnitDays
At 2025-06-30447USD
At 2024-12-31369USD

Pre-tax income or loss from continuing operations

Income or loss from continuing operations before income taxes and noncontrolling interests. It excludes discontinued operations and is not net income.

PeriodValueUnitDays
2025-04-01 to 2025-06-30-2,664,611USD91
2025-01-01 to 2025-06-30-4,288,829USD181
2024-04-01 to 2024-06-30-1,726,537USD91
2024-01-01 to 2024-06-30-3,113,441USD182

Net income available to common stockholders

Net income after preferred dividends and similar adjustments, the numerator for basic earnings per share. It can be lower than reported net income.

PeriodValueUnitDays
2025-04-01 to 2025-06-30-2,664,611USD91
2025-01-01 to 2025-06-30-4,324,024USD181
2024-04-01 to 2024-06-30-1,726,537USD91
2024-01-01 to 2024-06-30-3,113,441USD182

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

PeriodValueUnitDays
2025-04-01 to 2025-06-30936,205USD91
2025-01-01 to 2025-06-301,882,404USD181
2024-04-01 to 2024-06-30754,963USD91
2024-01-01 to 2024-06-301,277,002USD182

Nonoperating interest expense

Interest expense presented outside operating results. It differs from total interest expense when some borrowing cost is classified as operating or capitalized.

PeriodValueUnitDays
2025-04-01 to 2025-06-301,142USD91
2025-01-01 to 2025-06-302,306USD181

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

PeriodValueUnitDays
2025-04-01 to 2025-06-3027,699USD91
2025-01-01 to 2025-06-3060,577USD181

Proceeds from issuing common stock

Cash received from issuing common stock during the period. It is gross of costs only where the filer reports it so, and it does not include noncash issuances.

PeriodValueUnitDays
2025-01-01 to 2025-06-303,118,870USD181

Inspect the source

Entity
STRIVE, INC. / CIK 0001920406
Captured
SEC response SHA-256
cfd487d71bae9db4f393d68411435593262988a96682b8a177218a55607d4f8b

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001920406.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))